Wall Street analysts expect that Aspen Aerogels Inc (NYSE:ASPN) will post earnings of ($0.13) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Aspen Aerogels’ earnings, with the highest EPS estimate coming in at ($0.11) and the lowest estimate coming in at ($0.14). Aspen Aerogels posted earnings per share of ($0.25) in the same quarter last year, which would indicate a positive year-over-year growth rate of 48%. The business is scheduled to issue its next quarterly earnings report on Thursday, February 22nd.

According to Zacks, analysts expect that Aspen Aerogels will report full-year earnings of ($0.88) per share for the current financial year, with EPS estimates ranging from ($0.89) to ($0.86). For the next financial year, analysts forecast that the company will post earnings of ($0.38) per share, with EPS estimates ranging from ($0.41) to ($0.35). Zacks’ EPS averages are a mean average based on a survey of analysts that that provide coverage for Aspen Aerogels.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, November 2nd. The construction company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.01. Aspen Aerogels had a negative net margin of 22.72% and a negative return on equity of 21.86%. The firm had revenue of $27.20 million during the quarter, compared to analysts’ expectations of $28.23 million. During the same period last year, the company earned ($0.13) earnings per share. The business’s revenue was down 8.1% on a year-over-year basis.

Separately, Zacks Investment Research raised shares of Aspen Aerogels from a “hold” rating to a “buy” rating and set a $5.50 price target on the stock in a research report on Thursday, November 9th.

Aspen Aerogels (NYSE ASPN) traded up $0.14 on Tuesday, hitting $4.96. 33,800 shares of the company were exchanged, compared to its average volume of 55,399. Aspen Aerogels has a one year low of $3.84 and a one year high of $5.14.

In other Aspen Aerogels news, major shareholder Craig A. Huff sold 2,895,981 shares of Aspen Aerogels stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $4.30, for a total value of $12,452,718.30. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 16.80% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the business. Reservoir Operations L.P. increased its stake in shares of Aspen Aerogels by 0.4% in the third quarter. Reservoir Operations L.P. now owns 2,908,270 shares of the construction company’s stock worth $12,651,000 after purchasing an additional 12,289 shares in the last quarter. Oaktop Capital Management II L.P. increased its stake in shares of Aspen Aerogels by 14.6% in the third quarter. Oaktop Capital Management II L.P. now owns 1,399,001 shares of the construction company’s stock worth $6,086,000 after purchasing an additional 177,953 shares in the last quarter. Heartland Advisors Inc. grew its stake in Aspen Aerogels by 0.8% during the second quarter. Heartland Advisors Inc. now owns 927,066 shares of the construction company’s stock valued at $4,125,000 after acquiring an additional 7,066 shares in the last quarter. Tocqueville Asset Management L.P. grew its stake in Aspen Aerogels by 1.1% during the second quarter. Tocqueville Asset Management L.P. now owns 856,055 shares of the construction company’s stock valued at $3,809,000 after acquiring an additional 9,400 shares in the last quarter. Finally, Royce & Associates LP grew its stake in Aspen Aerogels by 12.8% during the third quarter. Royce & Associates LP now owns 660,746 shares of the construction company’s stock valued at $2,874,000 after acquiring an additional 74,792 shares in the last quarter. 74.40% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “-$0.13 Earnings Per Share Expected for Aspen Aerogels Inc (ASPN) This Quarter” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.dailypolitical.com/2017/12/15/0-13-earnings-per-share-expected-for-aspen-aerogels-inc-aspn-this-quarter.html.

About Aspen Aerogels

Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.

Get a free copy of the Zacks research report on Aspen Aerogels (ASPN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.